Markus Hell

1.1k total citations
37 papers, 677 citations indexed

About

Markus Hell is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Markus Hell has authored 37 papers receiving a total of 677 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 13 papers in Epidemiology and 7 papers in Clinical Biochemistry. Recurrent topics in Markus Hell's work include Clostridium difficile and Clostridium perfringens research (9 papers), Viral gastroenteritis research and epidemiology (8 papers) and Bacterial Identification and Susceptibility Testing (7 papers). Markus Hell is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (9 papers), Viral gastroenteritis research and epidemiology (8 papers) and Bacterial Identification and Susceptibility Testing (7 papers). Markus Hell collaborates with scholars based in Austria, Germany and Netherlands. Markus Hell's co-authors include Simon Auer, Franz Allerberger, Wolfgang Sperl, Barbara Kofler, Jan Marco Kern, Daniela Schmid, Eric Claassen, Neil Jones, Steliana Huhulescu and Alexandra Berger and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Emerging infectious diseases.

In The Last Decade

Markus Hell

36 papers receiving 642 citations

Peers

Countries citing papers authored by Markus Hell

Since Specialization

Citations

This map shows the geographic impact of Markus Hell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Hell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Hell more than expected).

Fields of papers citing papers by Markus Hell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Hell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Hell. The network helps show where Markus Hell may publish in the future.

Co-authorship network of co-authors of Markus Hell

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Hell. A scholar is included among the top collaborators of Markus Hell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Hell. Markus Hell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Three prolonged outbreaks of metallo-β-lactamase-producing Pseudomonas aeruginosa in an Upper Austrian hospital, 2017–2023 2024 ·Microbiology Spectrum ·Adriana Cabal Rosel, (unknown), (unknown), Anna Stöger, Burkhard Springer, Stefan Bletz, Alexander Mellmann, Patrick Hyden, Rainer Hartl, (unknown), (unknown), Markus Hell, (unknown), (unknown), (unknown), (unknown), Werner Ruppitsch	1
2	Greater attention to flexible hospital designs and ventilated clinical facilities are a pre-requisite for coping with the next airborne pandemic 2023 ·Clinical Microbiology and Infection ·H. Humphreys, Martine De Vos, Elisabeth Presterl, Markus Hell	1
3	Infection prevention and control policies in hospitals and prevalence of highly resistant microorganisms: an international comparative study 2022 ·Antimicrobial Resistance and Infection Control ·(unknown), Anne F. Voor in ’t holt, Emine Alp, Markus Hell, Nicola Petrosillo, Elisabeth Presterl, Athanasios Tsakris, Juliëtte A. Severin, Martine De Vos, (unknown)	7
4	Specialist training in medical microbiology across Europe in 2021—an update on the actual training situation based on a survey 2021 ·Clinical Microbiology and Infection ·Maeve Doyle, Breida Boyle, (unknown), Jane Holland, (unknown), Markus Hell, (unknown), Truls Michael Leegaard	6
5	Staffing for infectious diseases, clinical microbiology and infection control in hospitals in 2015: results of an ESCMID member survey 2016 ·Clinical Microbiology and Infection ·Yaakov Dickstein, Ran Nir‐Paz, Céline Pulcini, B. Cookson, B. Beović, Evelina Tacconelli, Dilip Nathwani, Rossitza Vatcheva-Dobrevska, Jesús Rodríguez‐Baño, Markus Hell, Henri Saenz, Leonard Leibovici, (unknown)	38
6	Clostridium difficile ribotypes in Austria: a multicenter, hospital-based survey 2015 ·Wiener klinische Wochenschrift ·(unknown), Alexander Indra, Daniela Schmid, Steliana Huhulescu, Erica Simons, Markus Hell, (unknown), Franz Allerberger	11
7	Molekulare Diagnostik von Methicillin-resistentem Staphylococcus aureus 2015 ·Der Hautarzt ·Markus Hell, Jan Bauer, Martin Laimer	1
8	Cytomegalovirus reactivation and its clinical impact in patients with solid tumors 2015 ·Infectious Agents and Cancer ·Konstantin Schlick, (unknown), Jutta Auberger, Jan Marco Kern, Markus Hell, Florian Hohla, Georg Hopfinger, Richard Greil	35
9	Clostridium-difficile-Infektion (CDI): Prävention, Diagnostik, Therapie 2014 ·Florian Thalhammer, Günter Weiß, Franz Allerberger, Petra Apfalter, Rainer Gattringer, (unknown), Andrea Grisold, Markus Hell, Christoph Högenauer, Oskar Janata, Robert Krause, Christian Madl, (unknown), Wolfgang Petritsch, Robert Sauermann, Herbert Tilg, (unknown), Christoph Wenisch	1
10	Active Anti-Microbial Effects of Larch and Pine Wood on Four Bacterial Strains 2013 ·BioResources ·(unknown), Thomas Schnabel, (unknown), (unknown), Alexander Petutschnigg, Gertie Janneke Oostingh, Markus Hell	32
11	Probiotics in Clostridium difficile infection: reviewing the need for a multistrain probiotic 2013 ·Beneficial Microbes ·Markus Hell, (unknown), (unknown), Jan Marco Kern, Eric Claassen	47
12	Post‐traumatic Pseudallescheria apiosperma osteomyelitis: positive outcome of a young immunocompetent male patient due to surgical intervention and voriconazole therapy 2011 ·Mycoses ·Markus Hell, (unknown), (unknown), Elisabeth Presterl, Birgit Willinger, Sybren de Hoog, Michaela Lackner	9
13	Clostridium difficile infection: monoclonal or polyclonal genesis? 2011 ·Infection ·Markus Hell, (unknown), (unknown), (unknown), Matthias Maass, Steliana Huhulescu, A. Indra, Franz Allerberger	11
14	Clinical aspects of 2009 pandemic influenza A (H1N1) virus infection in Austria 2011 ·Infection ·Wolfgang Poeppl, Markus Hell, Harald Herkner, Brigitte Stoiser, György Bèla Fritsche, (unknown), (unknown), Rainer Gattringer, Nicholas F. Jones, Matthias Maass, Alexander Egle, Heinz Burgmann	37
15	Foodborne gastroenteritis outbreak in an Austrian healthcare facility caused by asymptomatic, norovirus-excreting kitchen staff 2011 ·Journal of Hospital Infection ·Daniela Schmid, Hung-Wei Kuo, Markus Hell, (unknown), I Lederer, (unknown), Burkhard Springer, Franz Allerberger	21
16	Effects of galanin message-associated peptide and neuropeptide Y against various non-albicans Candida strains 2011 ·International Journal of Antimicrobial Agents ·(unknown), Isabella Rauch, (unknown), Wolfgang Sperl, Markus Hell, Barbara Kofler	16
17	Nosocomial Staphylococcal scalded skin syndrome caused by intra‐articular injection 2010 ·Journal of the European Academy of Dermatology and Venereology ·Michael Emberger, Josef Koller, (unknown), Markus Hell, (unknown), Andrea Trost, Matthias Maass, Wolfgang Witte, Helmut Hintner, (unknown)	5
18	An outbreak of norovirus gastroenteritis in an Austrian hospital, winter 2006–2007 2009 ·Wiener klinische Wochenschrift ·R. Fretz, Daniela Schmid, Sandra Jelovcan, (unknown), (unknown), Michael Schirmer, Markus Hell, Franz Allerberger	21
19	Foodborne outbreak of hepatitis A, November 2007–January 2008, Austria 2008 ·European Journal of Clinical Microbiology & Infectious Diseases ·Daniela Schmid, R. Fretz, (unknown), Christoph König, (unknown), (unknown), (unknown), Markus Hell, (unknown), Michael Straßer, Franz Allerberger	25
20	In vitro Susceptibilities to Topical Antibiotics of Bacteria Isolated from the Surface of Clinically Symptomatic Eyes 2001 ·Ophthalmic Research ·Stefan Egger, Josef Ruckhofer, E. Alzner, Markus Hell, Wolfgang Hitzl, V. Huber‐Spitzy, Günther Grabner	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact